Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3
Min Huang(First Affiliated Hospital of Wannan Medical College), George F. Gao(Chinese Academy of Sciences), Pu Han(Chinese Academy of Sciences), Yu Hu(University of Science and Technology of China), Anqi Zheng(Chinese Academy of Sciences), Qihui Wang(Chinese Academy of Sciences), Sheng Niu(Shanxi Agricultural University), Zengyuan Zhang(Chinese Academy of Sciences), Pei Du(Chinese Academy of Sciences), Pengcheng Han(Chinese Academy of Sciences), Kefang Liu(Wenzhou Medical University), Ziliang Hu(Anhui University), Kaige Cui(Chinese Academy of Sciences), Yunfei Jia(Shanxi Agricultural University), Yufeng Xie(Chinese Academy of Sciences), Jianxun Qi(Chinese Academy of Sciences), Weiwei Li(Chinese Academy of Sciences), Xin Zhao(Chinese Academy of Sciences), Lili Wu(Chinese Academy of Sciences), Shixiong Hu(Shanxi Agricultural University), Qingwen He(Chinese Academy of Sciences), Linjie Li(Zhejiang University), Runchu Zhao(Anhui University), Bin Bai(Chinese Academy of Sciences), Xiaoyu Rong(Wenzhou Medical University), Bo Liu(Sun Yat-sen University), Honghui Liu(Chinese Academy of Sciences)
Cited by 101
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Viral targets for vaccines against COVID-19
|Nature reviews. Immunology|2020|1.1k